Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Frederick Briccetti

1PUBLICATIONS

29CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jun 02, 2021

Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.

Sara M Tolaney, Nabihah Tayob, Chau Dang

Pageof 1

Frequent Collaborators

1 joint publications

Sara M Tolaney

1 joint publications

Nabihah Tayob

1 joint publications

Steven J Isakoff

1 joint publications

Therese Mulvey

1 joint publications

Ron Bose

1 joint publications

Antonio C Wolff

1 joint publications

Katherine Reeder-Hayes

1 joint publications

Hope S Rugo

1 joint publications

Dan Zuckerman

1 joint publications

Vijayakrishna K Gadi

Frequent Collaborators

1 joint publications

Sara M Tolaney

1 joint publications

Nabihah Tayob

1 joint publications

Steven J Isakoff

1 joint publications

Therese Mulvey

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos